I Didn't Buy the SpaceX IPO. Here's Why, and What I Bought Instead.

SpaceX's market value has risen to $2.43 trillion after its IPO, while Kraken Robotics is highlighted as the more attractive risk-reward opportunity. Kraken, with a roughly $2 billion market cap and about CA$102 million in last-year revenue, is expected to get a major sales lift from its pending Covelya acquisition, which was projected at CA$249 million to CA$275 million in sales. The article is mostly an investment opinion piece, but it underscores growth in defense, subsea tech, and offshore energy markets.

Analysis

KRKNF is less a “single-product robotics” story than a leverage play on two procurement cycles that are moving out of phase with public-market expectations: defense underwater ISR and offshore energy inspection. The pending Covelya combination matters more for mix than headline revenue; it should reduce customer concentration, widen channel access, and make Kraken more financeable for larger end-market buyers who prefer bundled sensor stacks over point solutions. That creates a second-order benefit: once integrated, the company can sell into platform refreshes rather than one-off hardware orders, which usually improves backlog visibility and gross margin stability.

The market is likely underestimating how quickly subsea autonomy can go from “niche tech” to budget line item if naval forces keep shifting spend from steel to sensors. Drone and mine-countermeasure modernization tends to have long qualification cycles, but once a vendor is embedded, switching costs are high and follow-on revenue can compound for years. The bigger risk is not demand destruction so much as execution: integration slippage, customer acceptance delays, or a slip in defense procurement timing could turn a re-rating catalyst into a multiple compression event over the next 1-2 quarters.

Contrarianly, the consensus seems to be treating Kraken as a growth stock when the more interesting angle is that it may be a scarcity asset in a strategically favored category. If the acquisition closes cleanly and management shows any evidence of cross-sell conversion, the stock can sustain a premium even if near-term revenue beats are only modest. But because the name already embeds a lot of optionality, the reward profile is best expressed with limited downside structures or relative-value longs versus over-owned space/AI adjacencies that are more valuation-stretched and less tied to budgeted defense capex.

Key Decisions for Investors

• Long KRKNF on a 3-6 month horizon into and immediately after the Covelya close; thesis is multiple expansion from improved scale and better revenue visibility. Size modestly because a missed integration milestone could re-rate the stock down 20-30% quickly.
• Buy KRKNF Jan-2027 calls or call spreads instead of common stock if liquidity allows; the setup is a multi-quarter adoption story with asymmetric upside, while premium defines downside if defense and offshore project timing slips.
• Pair trade: long KRKNF vs short a basket of high-duration, unprofitable space/robotics names; this isolates the re-rating from actual revenue conversion and reduces exposure to broad “future tech” multiple compression.
• Add KRKNF only on pullbacks after confirmation of post-acquisition integration milestones; avoid chasing strength pre-close because the stock already has event premium and any delay could unwind it fast.
• Set a risk trigger: if post-close commentary does not show cross-sell traction within 1-2 quarters, reduce exposure by at least half and rotate into more visible defense infra names.